ArticleBMJ open quality2026
From screen to scalpel: safety, efficiency and diagnostic performance of a direct-to-surgery teledermatology pathway.
Article in BMJ open quality, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTeledermatology is increasingly used to triage urgent suspected skin cancer referrals. A direct-to-surgery pathway allows selected patients to proceed directly to biopsy or excision without a preliminary face-to-face consultation. This study evaluated the safety, efficiency and diagnostic performance of a direct-to-surgery teledermatology pathway within a large National Health Service (NHS) skin cancer service.
methodsA service evaluation was conducted at the University Hospitals of North Midlands. All teledermatology referrals received between February 2022 and July 2024 were reviewed. Demographics, pathway intervals, surgical outcomes, cancellations, histopathology and complications were extracted from electronic records. The primary outcome was compliance with the 28-day Faster Diagnosis Standard. Secondary outcomes included compliance with the 62-day referral-to-treatment target, surgical complications, cancellation rates and diagnostic concordance between teledermatology assessment and histopathology.
resultsOf 18 587 teledermatology referrals, 5120 were triaged to the direct-to-surgery pathway. Following exclusion of 20 miscoded entries and 1 duplicate record, 5099 patients were included. A total of 4830 patients underwent surgery and 4825 had definitive histopathological diagnoses. The median time from referral to histology reporting was 46 days. Compliance with the 28-day Faster Diagnosis Standard was 99.86% (5092/5099), substantially exceeding the national target of 75%. Among patients diagnosed with melanoma or squamous cell carcinoma, 75.5% (440/583) commenced treatment within the 62-day referral-to-treatment target. Histopathology identified malignant pathology in 35.5% of lesions and premalignant pathology in a further 15.5%. Among lesions with both a recorded teledermatology diagnosis and definitive histology, overall concordance was 41.5% (1113/2679) with fair agreement (Cohen's κ=0.34). The overall complication rate was 1.3%.
conclusionsThis large single-centre evaluation demonstrates that a direct-to-surgery teledermatology pathway can safely support high-volume skin cancer surgery while achieving excellent compliance with the Faster Diagnosis Standard. Low complication rates and efficient progression through the diagnostic pathway support the use of teledermatology as an effective risk-stratification tool within contemporary skin cancer services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.